Cure My Disease

Don't miss your cure!

 Log in / Sign up

New MRI dye tested against standard for spotting kidney and adrenal issues

NCT ID NCT07040865

Recruiting now Diagnosis Sponsor: Insel Gruppe AG, University Hospital Bern Source: ClinicalTrials.gov ↗

First seen Nov 19, 2025 · Last updated May 08, 2026 · Updated 21 times

Summary

This study compares a newer MRI contrast agent, gadopiclenol, to the standard agent, gadobutrol, to see if it works just as well for imaging the kidneys and adrenal glands. About 104 adults with incidental findings in these organs will be randomly assigned to receive one of the two dyes during a single MRI session. The goal is to determine if the newer agent provides equally clear images for diagnosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUSPECT RENAL AND ADRENAL IMAGING FINDINGS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Diagnostic, Interventional and Pediatric Radiology Inselspital, University of Bern

    RECRUITING

    Bern, 3010, Switzerland

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

SUSPECT RENAL AND ADRENAL IMAGING FINDINGS SUSPECT RENAL AND ADRENAL IMAGING FINDINGS